Recalls / Class III
Class IIID-0630-2021
Product
Levetiracetam Tablets USP, 250 mg UD 100 Tablets (10x10) boxes, Rx Only, Distributed By: McKesson Corporation 4971 Southridge Blvd., Suite 101 Memphis, TN 38141 Manufactured by: Aurobindo Pharma Limited Hyderabad-500 090, India NDC 63739-795-10
- Affected lot / code info
- Lot: 0000124916 Exp. 09/30/2022
Why it was recalled
Labeling; Wrong Barcode; error in the machine-readable barcode which could result in some units being read as Naproxen Tablets 500 mg. Product is labeled correctly as Levetiracetam
Recalling firm
- Firm
- McKesson Corporation dba McKesson Drug Company
- Notification channel
- Letter
- Type
- Voluntary: Firm initiated
- Address
- 4853 Crumpler Rd, N/A, Memphis, Tennessee 38141-8301
Distribution
- Quantity
- 210 cartons
- Distribution pattern
- Nationwide in the US
Timeline
- Recall initiated
- 2021-05-26
- FDA classified
- 2021-06-15
- Posted by FDA
- 2021-06-16
- Terminated
- 2022-09-29
- Status
- Terminated
Source: openFDA Drug Enforcement endpoint. Recall record D-0630-2021. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.